Related Experiment Video
Updated: Jan 19, 2026
06:20
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
7.7K
The Case for Dosimetry in Alpha-Emitter Therapy.
1The Russell H. Morgan Department of Radiology and Radiological Science, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Journal of Medical Imaging and Radiation Sciences
|September 21, 2019
Summary
Radiopharmaceutical therapy (RPT) using alpha-particle emitters shows promise for widespread cancer. Dosimetry enables precision medicine by imaging RPT agent biodistribution, optimizing treatment and minimizing toxicity.
Area of Science:
- Oncology
- Nuclear Medicine
- Radiopharmaceutical Therapy
Background:
- Patients with distant metastatic cancer have a poor prognosis despite current treatments like chemotherapy and biologics.
- Radiopharmaceutical therapy (RPT) utilizing alpha-particle-emitting radionuclides demonstrates effectiveness against disseminated disease.
- Alpha-particle emitters induce DNA double-strand breaks due to their high energy density and short range, leading to potent tumor cell killing.
Purpose of the Study:
- To highlight the potential of radiopharmaceutical therapy (RPT) with alpha-emitters for treating widespread cancer.
- To emphasize the role of dosimetry in optimizing RPT by enabling precision medicine approaches.
- To discuss the unique advantage of imaging RPT agent biodistribution for treatment planning and toxicity management.
Main Methods:
- Review of the efficacy of alpha-particle-emitting radionuclides in preclinical and clinical settings.
- Discussion of the physical properties of alpha particles and their mechanism of action on DNA.
- Exploration of nuclear medicine imaging modalities for visualizing RPT agent biodistribution.
- Emphasis on the application of dosimetry for personalized RPT treatment strategies.
Main Results:
- Alpha-particle RPT is effective against widespread metastatic disease.
- The high potency of alpha-emitters can lead to significant toxicity.
- Biodistribution of RPT agents can be imaged, offering a unique advantage over other systemic therapies.
Conclusions:
- Radiopharmaceutical therapy with alpha-emitters offers a potent strategy for managing metastatic cancer.
- Dosimetry, combined with imaging, is crucial for implementing precision medicine in alpha-particle RPT.
- This approach allows for tailored treatment to maximize efficacy and minimize toxicity.
More Related Videos
Related Concept Videos
02:59Biological Effects of Radiation
17.6K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
17.6K
01:28Isotopes and Radioisotopes
11.1K
In the early 1900s, English chemist Frederick Soddy realized that an element could have atoms with different masses that were chemically indistinguishable. These different types are called isotopes — atoms of the same element that differ in mass. Isotopes differ in mass because they have different numbers of neutrons but are chemically identical because they have the same number of protons. Soddy was awarded the Nobel Prize in Chemistry in 1921 for this discovery.
An isotope containing...
An isotope containing...
11.1K
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
510
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
510
03:23Types of Radioactivity
19.4K
The most common types of radioactivity are α decay, β decay, γ decay, neutron emission, and electron capture.
Alpha (α) decay is the emission of an α particle from the nucleus. For example, polonium-210 undergoes α decay:
Alpha (α) decay is the emission of an α particle from the nucleus. For example, polonium-210 undergoes α decay:
19.4K
01:29Positron Emission Tomography
7.0K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
7.0K
01:05Absorption of Radiation
1.2K
The rate of heat transfer by emitted radiation is described by the Stefan-Boltzmann law of radiation:
1.2K